COVID-19

Study conducted at Shamir (Assaf Harofeh) Medical Center - Sagol Center for Hyperbaric Medicine and Research, demonstrates that Hyperbaric oxygen therapy (HBOT) can induce neuroplasticity and improve cognitive, psychiatric, fatigue, sleep and pain symptoms of patients suffering from post-COVID-19 condition. HBOT’s beneficial effect may be attributed to increased brain perfusion and neuroplasticity in regions associated with cognitive and emotional roles.

Data and Studies from The Sagol Center

More Studies